Skip to main content
Log in

Chasing biotech across Europe

  • Feature
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

European governments recognize that the biotech industry is important to their economic development, but can the sector overcome the obstacles hindering its growth?

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Barcelona's Biomedical Research Park.

References

  1. Anonymous. Biotechnology in Europe 2006 Comparative Study (Critical I, Banbury, UK, 2007).

  2. Sawhney, S. & Nasto, B. Spectrum Life Sciences (Decision Resources, Waltham, MA, USA, 2002).

    Google Scholar 

  3. European Commission. Life Sciences And Biotechnology—A Strategy For Europe (EC, Belgium, 2002). <http://ec.europa.eu/biotechnology/pdf/com2002-27_en.pdf>

  4. Brinkhorst, L.J. & Gennip, C. Life Sciences Monitor (Dutch Ministry of Economics, The Hague, 2005). <http://www.fractal.org/Life-Science-Technology/Life-Sciences-Monitor-2005.pdf>

  5. Ketels, C. in Innovative City and Business Regions, Structural Changes in Europe 3, 56–59 (Hagbarth Publications, Bollschweil, Germany, 2004).

    Google Scholar 

  6. Anonymous. The German Biotechnology Sector (Federal Ministry for Education and Research, Bonn, 2007).

Download references

Author information

Authors and Affiliations

Authors

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nasto, B. Chasing biotech across Europe. Nat Biotechnol 26, 283–288 (2008). https://doi.org/10.1038/nbt0308-283

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0308-283

  • Springer Nature America, Inc.

This article is cited by

Navigation